1. Home
  2. PM vs NVO Comparison

PM vs NVO Comparison

Compare PM & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Philip Morris International Inc

PM

Philip Morris International Inc

HOLD

Current Price

$159.15

Market Cap

238.8B

Sector

Health Care

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$48.21

Market Cap

212.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PM
NVO
Founded
1987
1923
Country
United States
Denmark
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.8B
212.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PM
NVO
Price
$159.15
$48.21
Analyst Decision
Strong Buy
Buy
Analyst Count
9
11
Target Price
$190.44
$54.25
AVG Volume (30 Days)
5.8M
17.7M
Earning Date
02-05-2026
02-04-2026
Dividend Yield
3.74%
2.58%
EPS Growth
N/A
10.06
EPS
5.52
3.67
Revenue
$39,992,000,000.00
$49,580,393,058.00
Revenue This Year
$10.82
$7.77
Revenue Next Year
$7.66
$1.86
P/E Ratio
$28.49
$12.99
Revenue Growth
7.45
16.64
52 Week Low
$116.12
$43.08
52 Week High
$186.69
$109.04

Technical Indicators

Market Signals
Indicator
PM
NVO
Relative Strength Index (RSI) 58.23 47.09
Support Level $156.49 $47.52
Resistance Level $159.87 $50.75
Average True Range (ATR) 3.19 1.04
MACD 0.86 0.16
Stochastic Oscillator 87.50 44.54

Price Performance

Historical Comparison
PM
NVO

About PM Philip Morris International Inc

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: